Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAktis Oncology Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 4 | -$0.43 | -$0.28 | -$0.37 |
| Q2 2026 | 4 | -$0.52 | -$0.36 | -$0.44 |
| Q3 2026 | 4 | -$0.54 | -$0.37 | -$0.48 |
| Q4 2026 | 2 | -$0.67 | -$0.15 | -$0.32 |
| Q1 2027 | 2 | -$1.34 | -$0.30 | -$0.63 |
| Q2 2027 | 1 | -$1.42 | -$0.32 | -$0.67 |
| Q3 2027 | 1 | -$1.53 | -$0.34 | -$0.72 |
| Q4 2027 | 2 | -$1.57 | -$0.35 | -$0.74 |
| Q1 2028 | 3 | -$1.35 | -$0.30 | -$0.63 |
| Q2 2028 | 2 | -$1.33 | -$0.30 | -$0.62 |
| Q3 2028 | 2 | -$1.43 | -$0.32 | -$0.67 |
| Q4 2028 | 3 | -$1.41 | -$0.31 | -$0.66 |
Aktis Oncology Inc Earnings Date And Information
Aktis Oncology Inc last posted its earnings results on Monday, May 11th, 2026. The company reported $-0.38 earnings per share for the quarter, missing analysts' consensus estimates of $-0.372 by $0.008. The company had revenue of 3.23 M for the quarter and had revenue of 6.50 M for the year. Aktis Oncology Inc has generated $-1 earnings per share over the last year ($-1.19 diluted earnings per share) and currently has a price-to-earnings ratio of -23.63. Aktis Oncology Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Aktis Oncology Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/30/2026 | Q1 2026 | N/A | -$0.33 | N/A | $2.23 M | $3.23 M |
| 12/31/2025 | Q4 2025 | N/A | -$0.28 | N/A | $3.28 M | $1.87 M |
| 12/31/2024 | Q4 2024 | N/A | -$0.23 | N/A | $9.30 M | $933.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aktis Oncology Inc Earnings: FAQ's
The conference call for Aktis Oncology Inc's latest earnings report can be listened to online.
The conference call transcript for Aktis Oncology Inc's latest earnings report can be read online.
Aktis Oncology Inc (:AKTS) has a recorded annual revenue of $6.50 M.
Aktis Oncology Inc (:AKTS) has a recorded net income of $-63,731,000.Aktis Oncology Inc has generated $-1.19 earnings per share over the last four quarters.
Aktis Oncology Inc (:AKTS) has a price-to-earnings ratio of -23.63 and price/earnings-to-growth ratio is -0.24.